Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oral Anticoagulant”

424 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 424 results

Not applicableNot Yet RecruitingNCT07441382
What this trial is testing

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation (AF)StrokeHemorrhage+4 more
Guangdong Provincial People's Hospital 200
Not applicableStudy completedNCT03563937
What this trial is testing

Real-world Comparative Effectiveness of Stroke Prevention in Patients With Atrial Fibrillation Treated With Factor Xa Non-vitamin-K Oral Anticoagulants (NOACs) vs. Phenprocoumon

Who this might be right for
Atrial Fibrillation
Bayer 64,920
Large-scale testing (Phase 3)Looking for participantsNCT05387954
What this trial is testing

PFO Closure, Oral Anticoagulants or Antiplatelet Therapy After PFO-associated Stroke in Patients Aged 60 to 80 Years

Who this might be right for
Cryptogenic Ischemic StrokePatent Foramen Ovale
Assistance Publique - Hôpitaux de Paris 792
Not applicableStudy completedNCT06239402
What this trial is testing

Therapeutic Strategy with Direct Oral Anticoagulants and Antiaggregant Drugs in Ischemic Heart Disease

Who this might be right for
Atrial Fibrillation
Istituti Clinici Scientifici Maugeri SpA 394
Not applicableStudy completedNCT03455439
What this trial is testing

Risk Factors of Outcomes Associated With Disease Progression in Patients With Atrial Fibrillation and Heart Failure (HF) Who Are Receiving a Direct Oral Anticoagulant (Rivaroxaban)

Who this might be right for
Heart Failure
Bayer 552
Not applicableNot Yet RecruitingNCT07327853
What this trial is testing

How Often Does the Fecal Test for Occult Blood Turn Positive After Using Blood Thinners?

Who this might be right for
Gastrointestinal BleedingAntiplatelet AgentsOral Anticoagulant Therapy
Jordan Collaborating Cardiology Group 200
Not applicableUnknownNCT04977076
What this trial is testing

Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary Intervention

Who this might be right for
Atrial FibrillationCoronary Artery DiseaseAnticoagulants
Zuyderland Medisch Centrum 1,214
Early research (Phase 1)Study completedNCT01954238
What this trial is testing

Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers

Who this might be right for
Healthy Volunteers
Green Cross Corporation 46
Large-scale testing (Phase 3)Study completedNCT03153150
What this trial is testing

Start or STop Anticoagulants Randomised Trial (SoSTART)

Who this might be right for
Intracranial HemorrhagesIntracranial Hemorrhage, HypertensiveSubarachnoid Hemorrhage+6 more
University of Edinburgh 203
Large-scale testing (Phase 3)Looking for participantsNCT04867837
What this trial is testing

Study of OCTAPLEX in Patients With Acute Major Bleeding on DOAC Therapy With Factor Xa Inhibitor

Who this might be right for
Acute Major Bleeding
Octapharma 260
Not applicableStudy completedNCT03285373
What this trial is testing

This Study Observes the Use of New Oral Anticoagulants (NOACs) in Patients With a Heart Rhythm Disorder in Spain

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 1,008
Large-scale testing (Phase 3)Study completedNCT00680186
What this trial is testing

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

Who this might be right for
Thromboembolism
Boehringer Ingelheim 2,589
Large-scale testing (Phase 3)UnknownNCT02544932
What this trial is testing

Pleotropic Effect of New Oral Anticoagulants

Who this might be right for
Atrial Fibrillation
Kyunghee University Medical Center 55
Not applicableLooking for participantsNCT05928091
What this trial is testing

Evaluation of the Impact of an Expert Opinion During the Management of Patients With Severe Bleeding on Oral Anticoagulants.

Who this might be right for
Hemorrhage
University Hospital, Clermont-Ferrand 1,000
Not applicableStudy completedNCT04662515
What this trial is testing

NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications

Who this might be right for
Surgery, OralHemorrhagePostoperative Complications+3 more
Malmö University 216
Not applicableStudy completedNCT06220422
What this trial is testing

Assessment of a Procedure for Managing Oral Anticoagulants (NACO) in the Management of Fractures

Who this might be right for
Femur Fracture
Hôpital NOVO 127
Not applicableUnknownNCT05469308
What this trial is testing

Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation

Who this might be right for
Oral AnticoagulantAdherence
Centre Hospitalier Universitaire, Amiens 705
Post-approval studies (Phase 4)Study completedNCT01127984
What this trial is testing

Pocket Haematoma Prevention in Patients Who Required Implantation/Replacement of a Pacemaker or Implantable Cardiac Defibrillator. The PHP Study.

Who this might be right for
Pacemaker ImplantationPocket Hematoma and BleedingAntiplatelet Therapy or Oral Anticoagulants
Careggi Hospital 100
Post-approval studies (Phase 4)Study completedNCT00711308
What this trial is testing

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Who this might be right for
Acute Pulmonary Embolism
Complejo Hospitalario Xeral-Calde 102
Large-scale testing (Phase 3)UnknownNCT01924325
What this trial is testing

Apixaban Versus Dual-antiplatelet Therapy (Clopidogrel and Aspirin) in Acute Non-disabling Cerebrovascular Events

Who this might be right for
Ischemic StrokeTIA
Xijing Hospital 10,000
Load More Results